These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30326868)

  • 1. The bone microenvironment promotes tumor growth and tissue perfusion compared with striated muscle in a preclinical model of prostate cancer in vivo.
    Mussawy H; Viezens L; Schroeder M; Hettenhausen S; Sündermann J; Wellbrock J; Kossow K; Schaefer C
    BMC Cancer; 2018 Oct; 18(1):979. PubMed ID: 30326868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo functional and morphological characterization of bone and striated muscle microcirculation in NSG mice.
    Mussawy H; Viezens L; Hauenherm G; Schroeder M; Schaefer C
    PLoS One; 2017; 12(8):e0183186. PubMed ID: 28800593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Quantification of Prostate Cancer-Associated Vascular Alterations in the Bone Microenvironment in vivo.
    Schroeder M; Viezens L; Sündermann J; Hettenhausen S; Hauenherm G; Wellbrock J; Mussawy H; Kossow K; Schaefer C
    Eur Surg Res; 2020; 61(6):188-200. PubMed ID: 33626542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of microvascular remodelling during tumor growth in bone.
    Fuhrhop I; Schroeder M; Rafnsdóttir SL; Viezens L; Rüther W; Hansen-Algenstaedt N; Schaefer C
    J Orthop Res; 2010 Jan; 28(1):27-31. PubMed ID: 19642113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femur window--a new approach to microcirculation of living bone in situ.
    Hansen-Algenstaedt N; Schaefer C; Wolfram L; Joscheck C; Schroeder M; Algenstaedt P; Rüther W
    J Orthop Res; 2005 Sep; 23(5):1073-82. PubMed ID: 15890486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumor dependent inhibition of tumor growth, angiogenesis, and perfusion of secondary breast cancer in bone.
    Schaefer C; Schroeder M; Fuhrhop I; Viezens L; Otten J; Fiedler W; Rüther W; Hansen-Algenstaedt N
    J Orthop Res; 2011 Aug; 29(8):1251-8. PubMed ID: 21381098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcirculation of secondary bone tumors in vivo: the impact of minor surgery at a distal site.
    Schaefer C; Fuhrhop I; Schroeder M; Viezens L; Otten J; Fiedler W; Rüther W; Hansen-Algenstaedt N
    J Orthop Res; 2010 Nov; 28(11):1515-21. PubMed ID: 20872590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.
    Podgorski I; Linebaugh BE; Sameni M; Jedeszko C; Bhagat S; Cher ML; Sloane BF
    Neoplasia; 2005 Mar; 7(3):207-23. PubMed ID: 15799821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.
    Lee HL; Pienta KJ; Kim WJ; Cooper CR
    Int J Oncol; 2003 Apr; 22(4):921-6. PubMed ID: 12632088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187.
    Reeves KJ; Hurrell JE; Cecchini M; van der Pluijm G; Down JM; Eaton CL; Hamdy F; Clement-Lacroix P; Brown NJ
    Int J Cancer; 2015 Apr; 136(7):1731-40. PubMed ID: 25156971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.
    Leunig M; Yuan F; Menger MD; Boucher Y; Goetz AE; Messmer K; Jain RK
    Cancer Res; 1992 Dec; 52(23):6553-60. PubMed ID: 1384965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
    Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
    Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel model for the investigation of orthotopically growing primary and secondary bone tumours using intravital microscopy.
    Klenke FM; Merkle T; Fellenberg J; Abdollahi A; Huber PE; Gebhard MM; Ewerbeck V; Sckell A
    Lab Anim; 2005 Oct; 39(4):377-83. PubMed ID: 16197704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib treatment reduces tumor growth and limits changes in microvascular properties after minor surgical intervention in an in vivo model of secondary breast cancer growth in bone.
    Schroeder M; Viezens L; Wellbrock J; Fiedler W; Rüther W; Algenstaedt P; Hansen-Algenstaedt N; Schaefer C
    J Surg Oncol; 2016 Apr; 113(5):515-21. PubMed ID: 26818116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
    Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
    Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.
    Yin J; Pollock C; Tracy K; Chock M; Martin P; Oberst M; Kelly K
    Mol Cell Biol; 2007 Nov; 27(21):7538-50. PubMed ID: 17709381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.